BioSpace News Archive

Drug Development

Research Roundup: Lab-on-a-Chip, Alzheimer’s Advances, Breast Cancer and More

There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.

May 2, 2019
·
6 min read
·
Mark Terry
Job Trends

BioSpace Movers and Shakers: May 3

Biopharma companies make changes to their C-suite leadership teams, with hires at uBiome, Enzyre, Sobi, Amylyx, Mission Therapeutics, and more.

May 2, 2019
·
5 min read
·
Alex Keown
Deals

MyoKardia to Report First Quarter 2019 Financial Results on Thursday, May 9, 2019

MyoKardia, Inc. announced that it will report first quarter 2019 financial and operating results on Thursday, May 9, 2019.

May 2, 2019
·
2 min read
ASIT biotech announces the achievement of new clinical and corporate development milestones

The treatment phase of the confirmatory phase III clinical study with gp-ASIT+™ in grass pollen rhinitis is now completed for all patients, in time before the grass pollen season, with no major safety concerns. DSMB recommends continuing the study without modification.

May 2, 2019
·
5 min read
FDA

FDA Approves First Dengue Fever Vaccine - with Restrictions

Dengvaxia is approved for dengue disease caused by serotypes 1-4 in people 9 through 16 years of age who are living in areas of the U.S. who have had a laboratory-documented previous infection.

May 2, 2019
·
2 min read
·
Mark Terry
Policy

uBiome Places Co-CEOS on Administrative Leave, Taps Interim CEO as Billing Investigation Continues

Days after the Federal Bureau of Investigation raided the offices of Bay Area-based uBiome over allegations of illegal billing practices, the company’s board of directors placed Jessica Richman and Zac Apte, the co-founders and co-chief executive officers of the company, on administrative leave.

May 2, 2019
·
2 min read
·
Alex Keown
Newly discovered gene mutation reduces fear and anxiety, and increases social interaction

Finnish researchers at the University of Eastern Finland and the University of Oulu have discovered of a new type of gene mutation that reduces fear and anxiety, and increases social interaction.

May 2, 2019
·
3 min read
Business

Tarlton Launches Non-Profit to Support Health and Education Initiatives

“Team Tarlton” will focus on fundraising for cancer research, support for biking programs, and working to create a vibrant local community

May 2, 2019
·
4 min read
Deals

Neos Therapeutics to Host First Quarter 2019 Financial and Operating Results Conference Call on May 9th, 2019

Neos Therapeutics, Inc. announced that it will report its first quarter 2019 financial results prior to the opening of U.S. financial markets on Thursday, May 9, 2019.

May 2, 2019
·
1 min read
Out-of-the-Box Integration of Genedata Bioprocess® with MODDE® Streamlines Bioprocess Development DOE

Direct integration of Genedata Bioprocess® and Umetrics® Suite MODDE® software enables seamless data flow and facilitates both design and execution of experiments in large-molecule process development

May 2, 2019
·
4 min read